肿瘤药学Issue(6)：416-421,6.DOI:10.3969/j.issn.2095-1264.2013.103
中晚期卵巢癌的治疗现状
Current Situation of the Therapies of Middle-advanced Ovarian Cancer
摘要
Abstract
Ovarian cancer had been the most difficult challenge in all gynecological tumors. Along with the ensemble medi-cal technology stepping forward, the treatment of ovarian cancer was continuously improved. Traditional radical operation and postoperative chemotherapy was still nonattribute-based approaches in ovarian cancer;neoadjuvant chemotherapy (NAC) and preoperative interventional chemoembolization strived for operation opportunity for advanced ovarian cancer patients who had lost operation opportunity;intraperitoneal hyperthermic chemotherapy (IPHC) could safely and effectively postpone recidivation and improve the quality of life for advanced ovarian cancer patients;targeted therapy and immunotherapy were the major trend in prognosis for advanced ovarian cancer patients. This article was aimed to review the current situation of the therapies of middle-advanced ovarian cancer and provide references to enhance the survival rate and quality of life of middle-advanced ovarian can-cer.关键词
中晚期卵巢癌/根治性手术/新辅助化疗/腹腔热灌注化疗/靶向治疗/免疫治疗Key words
Advanced ovarian cancer/Radical operation/Neoadjuvant chemotherapy/Preoperative interventional chem-oembolization/Intraperitoneal hyperthermic chemotherapy/Targeted therapy/Immunotherapy分类
医药卫生引用本文复制引用
蒋静(综述),谢宛玉(审校),曹建国(审校)..中晚期卵巢癌的治疗现状[J].肿瘤药学,2013,(6):416-421,6.基金项目
国家自然科学基金项目资助（No.81172375）。 （）
